In 2024, the European biosimilar market was valued at USD 13,864 million. Forecasts indicate significant expansion, with the market expected to reach USD 59,733.3 million by 2033 at a CAGR of 17.1% from 2025 to 2033. Factors such as supportive reimbursement policies, increased production capacity, and ongoing technological innovations are fueling market growth. https://www.imarcgroup.com/europe-biosimilar-market